Connect to Frankfurt: Operational excellence in technology transfer
In this Connect to Frankfurt session, Clarissa J. Van Allen, Global Senior Manager, Technology Transfer, Oral Solid Dose at Thermo Fisher Scientific, discusses the value of an effective and efficient technology transfer project in the drug development and commercialization process, and how Thermo Fisher offers solutions to tech transfer project management.
As part of our conference track devoted to Future Therapies, this session explores technology transfer project management with leading experts in the drug devleopment and commercialization industry.
Technology transfer project management: why is it important?
Technology transfer refers to the process by which an original innovator makes their production technology available to commercial partners, including any aspects of the drug production process and business processes. Internal technology transfers occur between a drug’s development and commercial stages within the same organization, while external technology transfers are from an external developer to a commercial-scale manufacturing facility. technology transfers constitute a crucial part of the progression of a successful product – from its discovery, development, and clinical testing right through to a products full-scale commercialization.
Van Allen’s presentation emphasized the importance of an effective and efficient technology transfer project management strategy.
The right method for consistent and reliable technology transfer execution
In her presentation, Van Allen highlighted some key parameters for ensuring a technology transfer project’s success. A robust methodology was at the centre of Van Allen’s strategy for rapid and predictable delivery of technology transfer project timelines and expectations. The key points she discussed included:
1) Proactive risk mitigation.
Actions under this parameter included a documented action plan to resolve each risk and flagging support needs for each site and facility.
2) Optimized governance and escalation pathways stemming from site-level governance and global networks to troubleshoot and mitigate issues.
3) Local project review boards.
4) Seamless execution between project phases.
This should be achieved through dependable ‘right first-time’ delivery.
5) A single point-of-contact for seamless project management.
6) A global network of trusted partner’s throughout the development and commercial pipelines.
Van Allen also included Thermo Fisher Scientific’s suite of digital toolkits for enhanced process oversight in order to provide what she termed “trust, transparency, and accountability”.
Case studies
Two case studies were presented as part of Van Allen’s presentation. The first covered a small, multinational pharmaceutical company looking to produce a COVID-19 treatment in a three-month timeline. With limited resources, the company turned to Thermo Fisher Scientific to conduct multiple, concurrent technology transfer projects across three sites while meeting regulatory requirements for both the US and EU markets. With a single point-of-contact and internal information sharing across the sites, successful technology transfer projects were executed in the span of 4–6 months.
In another instance, the US FDA issued an emergency use authorization for COVID-19 dual tablet treatments. Speed-to-market was crucial to the technology transfer project for this case, as competitors of the client were in the process of developing similar products. By managing the technology transfer to commercialization in tandem with development activities, the team were able to deliver an effective COVID-19 treatment to market with efficiency and robustness and a successful launch.
The future of technology transfer
With an effective execution strategy and robust methodology, Van Allen emphasized the value of technology transfer programs as an integral part of drug development and commercialization. With appropriate tools and management systems, technology transfers can aid in synergising complimentary needs at every step of a product’s development through to its launch in the global market.
Want to learn more? Explore all on-demand sessions Connect to Frankfurt has to offer by registering here.
Related News
-
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News CPHI North America Lookahead: Facilitating ‘meaningful conversations’ on needs and solutions
CPHI NA takes place as a SMART event this year, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA. -
News Early development demand continues to boost prospects for smaller CDMOs: CPHI Worldwide panel
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market -
News CPHI Worldwide is back, and this time it’s hybrid
A new in-person and online edition of CPHI Worldwide, transforming your event experience. -
News 5 Highlights from the Pharmapack Europe Content Programme
Pharmapack Europe is back! Join us online from 27 September as we kick off our two-week long content programme, a great precursor to the in-person event from 13-14 October at the Paris Expo Porte de Versailles. -
News Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPHI panel
CPHI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges -
News UPDATED: The CPHI Discover Blog
Bookmark this page for regular updates on the rich variety of content coming your way via CPHI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda -
News COVID-19 has exacerbated contract manufacturing challenges but industry continues to respond well to crisis: experts
Coronavirus pandemic has exacerbated manufacturing capacity constraints, particularly in injectable dose and viral vector production, CPHI audience told
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance